VANCOUVER, April 29, 2019 /CNW/ - WELL Health Technologies Corp. (TSX-V: WELL) ("WELL" or the "Company"), an owner operator of a portfolio of Primary Healthcare facilities; further positioning itself for M&A opportunities in Primary Healthcare and Digital Health marketplaces, announced today that Hamed Shahbazi, CEO, will present at the upcoming Bloom Burton & Co. Healthcare Investor Conference, which is being held on Tuesday, April 30 – Wednesday, May 1, 2019. The Conference will be held in the Metro Toronto Convention Centre, 255 Front St W, Toronto, Ontario.
Mr. Shahbazi will discuss the Company's recent acquisitions, as well as present an overview of WELL's clinical and digital operating businesses, M&A strategy, and its overarching objective to empower primary care doctors to provide the best and most advanced care possible while leveraging the latest trends in digital health.
WELL is scheduled to present on May 1st, 2019 at 3:30 PM EST. Mr. Shahbazi will be available for one on one meetings throughout the conference.
About the Bloom Burton & Co. Healthcare Investor Conference:
The Bloom Burton & Co. Healthcare Investor Conference brings together U.S., Canadian and international investors who are interested in the latest developments in the Canadian healthcare sector. Attendees will have an opportunity to obtain corporate updates from the premier Canadian publicly traded and private companies through presentations and private meetings.
About WELL Health Technologies Corp.
WELL is a unique company that operates primary health care facilities as well as a significant EMR or electronic medical records business that supports the digitization of such clinics. WELL's overarching objective is to empower primary care doctors to provide the best and most advanced care possible leveraging the latest trends in digital health. In the last 12 months, WELL physicians served approximately 600,000 patient visits through its network of 19 medical clinics.
About Bloom Burton & Co.:
Bloom Burton & Co. (Bloom Burton Securities Inc.) is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies. Bloom Burton has an experienced team of medical, scientific, pharmaceutical, legal and capital markets professionals who perform a deep level of diligence, which combined with our creative and entrepreneurial approach, assists our clients in achieving the right monetization events. Bloom Burton and its affiliates provide capital raising, M&A advisory, equity research, business strategy and scientific consulting, advisory on direct investing and company creation and incubation services. Bloom Burton Securities Inc. is a member of the Investment Industry Regulatory Organization of Canada (IIROC) and is also a member of the Canadian Investor Protection Fund (CIPF).
This news release may contain "forward-looking statements" within the meaning of applicable securities laws. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive uncertainties, and contingencies. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause future results, performance or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by those forward-looking statements and the forward-looking statements are not guarantees of future performance. WELLHealth Technologies' expressed or implied by these forward-looking statements are subject to a number of risks, uncertainties, and conditions, many of which are outside of WELL Health Technologies Corp's control. For a description of the risks associated with WELL Health Technologies' business please refer to the "Risk Factors" section of WELL Health Technologies' annual information form dated March 6, 2018, which is available at www.sedar.com. Except as required by law, WELL Health Technologies disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, events or otherwise.
SOURCE WELL Health Technologies Corp.
For further information: Pouya Farmand, [email protected], (778) 867-4726